Metraipolis › archive › dc_f226dafb3583

Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes — Europe PMC PMID:42399394

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42399394
DOI
10.1038/s41433-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-10-18T11:49:08.707Z
SHA-256 of the archived text
6e6051d0a0b51d31c07c2e7f8ba6bd44ea7ae14ffaa1aa827b63d43fa81b3c93
Stable URL of this page
https://metraipolis.com/documento/dc_f226dafb3583

How to cite

Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes — Europe PMC PMID:42399394 — Europe PMC (en), https://europepmc.org/article/MED/42399394 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f226dafb3583 (Metraipolis archive dc_f226dafb3583, sha256 6e6051d0a0b51d31c07c2e7f8ba6bd44ea7ae14ffaa1aa827b63d43fa81b3c93)
BibTeX
@misc{dcf226dafb3583,
  title = {Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes — Europe PMC PMID:42399394},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42399394},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f226dafb3583; sha256 6e6051d0a0b51d31c07c2e7f8ba6bd44ea7ae14ffaa1aa827b63d43fa81b3c93},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42399394. Agents can read the archived copy with the MCP tool read_document.